Enzo Life Sciences introduces the CYTAG® SuperCGH + SNP Labeling Kit, optimized for dual comparative genomic hybridization CGH+SNP and CGH only. This innovative kit empowers cytogenetic researchers with enhanced performance and streamlined workflows.
The CYTAG® SuperCGH + SNP kit is ideally suited for biopsy samples and has been validated for use with blood, amniotic fluid, postnatal, and oncology samples. Its superior dynamic analytical range allows for analysis with DNA input as low as 100 ng for CGH+SNP and 50 ng for CGH only. The shortened workflow prepares samples for hybridization in under four hours, significantly reducing turnaround time.
Key benefits of the CYTAG® SuperCGH + SNP kit include:
- Optimized for low input samples
- Validated for various sample types (blood, amniotic fluid, postnatal, oncology)
- Excellent dynamic analytical range
- Shorter workflow (< 4 hours to hybridization)
- Superior DLR scores
- Ability to perform total genomic DNA analysis without amplification or complexity reduction
Comparative genomic hybridization (aCGH) is a powerful diagnostic tool for detecting DNA copy number variations associated with chromosome abnormalities, providing valuable insights into genetic disorders, cancers, and other genomic aberrations. The CYTAG® SuperCGH + SNP Labeling Kit further enhances this technique, providing higher labeled DNA yield and maintaining high specific activity even with minimal DNA input.
Learn more about the CYTAG® SuperCGH + SNP Labeling Kit at www.enzo.com/cgh